Summary
IDEXX LABORATORIES INC /DE (IDXX) filed an 8-K on March 14, 2019, to report a significant amendment to its Multicurrency Note Purchase and Private Shelf Agreement with Metropolitan Life Insurance Company (MetLife) and other institutional purchasers. The primary purpose of this amendment was to substantially increase the company's borrowing capacity under its shelf facility and facilitate a new debt issuance. Specifically, the amendment increased the total potential size of the shelf notes facility from $50 million to $150 million, demonstrating an expanded need for capital or a strategic decision to enhance liquidity. Alongside this increase, the company utilized the amended facility to issue $100 million of new senior promissory notes (Series C Notes) due March 14, 2029, bearing a fixed interest rate of 4.19%. The proceeds from this issuance are earmarked for general corporate purposes, including debt repayment, which could indicate a proactive approach to managing its debt structure and optimizing its cost of capital. Investors should note the extension of the issuance period to December 20, 2021, which provides flexibility for future financing needs.
Key Highlights
- 1IDEXX amended its Multicurrency Note Purchase and Private Shelf Agreement with MetLife and other institutional purchasers.
- 2The total size of the Shelf Notes facility was increased from $50 million to $150 million.
- 3The issuance period for Shelf Notes was extended from December 19, 2017, to December 20, 2021.
- 4IDEXX issued $100 million of new Series C Notes on March 14, 2019, under the amended agreement.
- 5The Series C Notes mature on March 14, 2029, and carry a fixed interest rate of 4.19% per annum.
- 6Proceeds from the Series C Notes are intended for general corporate purposes, including debt repayments.
- 7The agreement includes customary affirmative, negative, and financial covenants, including a consolidated leverage ratio test and subsidiary guarantees.